cefalexin
Commercial- Indications
- Bacterial infections
Company intelligence / Profile preview
Zhejiang Anglikang Pharmaceutical is a leading Chinese manufacturer of oral cephalosporin antibiotics and other pharmaceutical products. The company has a strong presence in both domestic and export markets with commercialized APIs and finished dosage forms. It has recently entered into innovative drug development through partnerships such as with Affinity Biopharma for tumor microenvironment-targeted therapies. No clinical-stage novel drugs are publicly disclosed as of June 2025.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Anglikang Pharmaceutical.